Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo

Cornea

Volumn 29, Issue 1, 2010, Pages 80-85

  Kusano, Mao ^a   Uematsu, Masafumi ^a   Kumagami, Takeshi ^a   Sasaki, Hitoshi ^b   Kitaoka, Takashi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Barrier function; Benzalkonium chloride; Corneal epithelium; Cytotoxicity; Preservative; Transepithelial electric resistance

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; BENZALKONIUM CHLORIDE; BORIC ACID; CHLORBUTOL; CHLORHEXIDINE GLUCONATE; EDETIC ACID; SILVER CHLORIDE; PRESERVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEAL TRANSEPITHELIAL ELECTRIC RESISTANCE; CYTOTOXICITY TEST; ELECTRIC RESISTANCE; ELECTRODE; EPITHELIUM CELL; EXPERIMENTAL RABBIT; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; IMPEDANCE; PATHOLOGY; RABBIT; TIGHT JUNCTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; ELECTRIC IMPEDANCE; EPITHELIUM, CORNEAL; MALE; PRESERVATIVES, PHARMACEUTICAL; RABBITS; TIGHT JUNCTIONS;

EID: 75649126943     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181a3c3e6     Document Type: Article

References (47)

1. Liaw J, Robinson JR. Ocular penetration enhancers. In: Mitra AK, ed. Ophthalmic Drug Delivery Systems. New York, NY: M. Dekker Inc; 1993: 369-381.
2. Green K. Electrophysiological and anatomical effects of cetylpyridinium chloride on the rabbit cornea. Acta Ophthalmol. 1976;54:145-159.
3. Saettone MF, Chetoni P, Cerbai R, et al. Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four b-blockers, and in vitro/in vivo toxic activity. Int J Pharm. 1996;142:103-113.
4. Sasaki H, Yamamura K, Mukai T, et al. Enhancement of ocular drug penetration. Crit Rev Ther Drug Carrier Syst. 1999;16:85-146.
5. Marsh RJ, Maurice DM. The influence of non-ionic detergents and other surfactants on human corneal permeability. Exp Eye Res. 1971;11:43-48.
6. Tonjum AM. Effects of benzalkonium chloride upon the corneal epithelium studied with scanning electron microscopy. Acta Ophthalmol. 1975;53:358-367.
7. Burstein NL. Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci. 1980;19:308-313.
8. Pfister RR, Burstein N. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol. 1976;15:246-259.
9. Gasset AR, Ishii Y, Kaufman HE, et al. Cytotoxicity of ophthalmic preservatives. Am J Ophthalmol. 1974;78:98-105.
10. Green K, Tonjum AM. The effect of benzalkonium chloride on the electropotential of the rabbit cornea. Acta Ophthalmol. 1975;53:348-357.
11. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377-390.
12. York M, Steiling W. A critical review of the assessment of eye irritation potential using the Draize rabbit eye test. J Appl Toxicol. 1998;18: 233-240.
13. North-Root H, Yackovich F, Demetrulias J, et al. Evaluation of an in vitro cell toxicity test using rabbit corneal cells to predict the eye irritation potential of surfactants. Toxicol Lett. 1982;14:207-212.
14. Kruszewski FH, Walker TL, DiPasquale LC. Evaluation of a human corneal epithelial cell line as an in vitro model for assessing ocular irritation. Fundam Appl Toxicol. 1997;36:130-140.
15. Furrer P, Plazonnet B, Mayer JM, et al. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm. 2000;207:89-98.
16. Burton ABG, York M, Lawrence RS. The in vitro assessment of severe eye irritants. Food Cosmet Toxicol. 1981;19:471-480.
17. Igarashi H, Northover AM. Increases in opacity and thickness induced by surfactants and other chemicals in the bovine isolated cornea. Toxicol Lett. 1987;39:249-254.
18. Prinsen MK. The chicken enucleated eye test (CEET): a practical (pre)screen for the assessment of eye irritation/corrosion potential of test materials. Food Chem Toxicol. 1996;34:291-296.
19. Gautheron P, Dukic M, Alix D, et al. Bovine corneal opacity and permeability test: an in vitro assay of ocular irritancy. Fundam Appl Toxicol. 1992;18:442-449.
20. Monti D, Chetoni P, Burgalassi S, et al. Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation. Int J Pharm. 2002;232:139-147.
21. Sasaki H, Igarashi Y, Nagano T, et al. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic betablockers. Pharm Res. 1995;12:1146-1150.
22. Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
23. Göbbels M, Spitznas M. Influence of artificial tears on corneal epithelium in dry-eye syndrome. Graefes Arch Clin Exp Ophthalmol. 1989;227: 139-141.
24. Göbbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefes Arch Clin Exp Ophthalmol. 1989; 227:142-144.
25. Joshi A, Maurice D, Paugh JR. A new method for determining corneal epithelial barrier to fluorescein in humans. Invest Ophthalmol Vis Sci. 1996;37:1008-1016.
26. Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma. 2003;12:486-490.
27. Mishima S, Gasset A, Klyce SD Jr, et al. Determination of tear volume and tear flow. Invest Ophthalmol. 1966;5:264-276.
28. Jordan A, Baum J. Basic tear flow. Does it exist? Ophthalmology. 1980;87: 920-930.
29. Uematsu M, Kumagami T, Kusano M, et al. Acute corneal epithelial change after instillation of benzalkonium chloride evaluated using a newly developed in vivo corneal transepithelial electric resistance measurement method. Ophthalmic Res. 2007;39:308-314.
30. Rojanasakul Y, Liaw J, Robinson JR. Mechanisms of action of some penetration enhancers in the cornea: laser scanning confocal microscopic and electrophysiology studies. Int J Pharm. 1990;66:131-142.
31. Rojanasakul Y, Robinson JR. Electrophysiological and ultrastructural characterization of the cornea during in vitro perfusion. Int J Pharm. 1990;63:1-16.
32. Chetoni P, Burgalassi S, Monti D, et al. Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Toxicol In Vitro. 2003;17:497-504.
33. Burgalassi S, Chetoni P, Monti D, et al. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett. 2001;122:1-8.
34. Narai A, Arai S, Shimizu M. Rapid decrease in transepithelial electrical resistance of human intestinal Caco-2 cell monolayers by cytotoxic membrane perturbents. Toxicol In Vitro. 1997;11:347-354.
35. Moyes SM, Smyth SH, Shipman A, et al. Parameters influencing intestinal epithelial permeability and microparticle uptake in vitro. Int J Pharm. 2007;337:133-141.
36. Blikslager AT, Moeser AJ, Gookin JL, et al. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87:545-564.
37. Balda MS, Whitney JA, Flores C, et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996; 134:1031-1049.
38. Holt M, Cogan DG. Permeability of excised cornea to ions as determined by measurements of impedance. Arch Ophthalmol. 1946;35:292-298.
39. Potts AM, Modrell RW. The transcorneal potential. Am J Ophthalmol. 1957;44:284-290.
40. Donn A, Maurice DM, Mills NL. Studies on the living cornea in vitro. I. Method and physiologic measurements. Arch Ophthalmol. 1959;62: 741-747.
41. Camber O, Edman P. Influence of some preservatives on the corneal permeability of pilocarpine and dexamethasone, in vitro. Int J Pharm. 1987;39:229-234.
42. Mullen W, Shepherd W, Labovitz J. Ophthalmic preservatives and vehicles. Surv Ophthalmol. 1973;17:469-483.
43. Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther. 2001;18:205-215.
44. Hubbard SA. Comparative toxicology of borates. Biol Trace Element Res. 1998;66:343-357.
45. Saarinen-Savolainen P, Järvinen T, Araki-Sasaki K, et al. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res. 1998;15:1275-1280.
46. Nakashima M, Nakamura T, Teshima M, et al. Breakdown evaluation of corneal epithelial barrier caused by antiallergic eyedrops using an electrophysiologic method. J Ocul Pharmacol Ther. 2008;24:43-51.
47. Ward SL, Walker TL, Dimitrijevich SD, et al. Evaluation of chemically induced toxicity using an in vitro model of human corneal epithelium. Toxicol In Vitro. 1997;11:121-139.